{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T13:48:39Z","timestamp":1780667319494,"version":"3.54.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.anndiagpath.2025.152602","type":"journal-article","created":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T15:37:35Z","timestamp":1766331455000},"page":"152602","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["From the archives of MD Anderson Cancer Center: Paraneoplastic autoimmune multiorgan syndrome (PAMS) associated with stroma-rich Castleman disease"],"prefix":"10.1016","volume":"81","author":[{"given":"Doaa","family":"Alqaidy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar A.","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annikka","family":"Weissferdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2025.152602_bb0005","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1056\/NEJM199012203232503","article-title":"Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia","volume":"323","author":"Anhalt","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0010","first-page":"193","article-title":"Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus","volume":"137","author":"Nguyen","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0015","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1046\/j.1523-1747.1998.00449.x","article-title":"Envoplakin and periplakin are components of the paraneoplastic pemphigus antigen complex","volume":"111","author":"Kiyokawa","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0020","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1046\/j.1523-1747.1998.00279.x","article-title":"The members of the plakin family of proteins recognized by paraneoplastic pemphigus antibodies include periplakin","volume":"111","author":"Mahoney","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0025","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1067\/mjd.2001.112222","article-title":"Clinical phenotype and anti-desmoglein autoantibody profile in paraneoplastic pemphigus","volume":"44","author":"Ohyama","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0030","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0140-6736(04)15539-6","article-title":"Castleman\u2019s tumours and production of autoantibody in paraneoplastic pemphigus","volume":"363","author":"Wang","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0035","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/bjd.13648","article-title":"Production of numerous autoantibodies in paraneoplastic pemphigus","volume":"172","author":"Hashimoto","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0040","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1001\/archderm.1992.01680180085011","article-title":"Histologic features of paraneoplastic pemphigus","volume":"128","author":"Horn","year":"1992","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0045","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1600-0560.1993.tb00644.x","article-title":"Paraneoplastic pemphigus: a subset of patients with pemphigus and neoplasia","volume":"20","author":"Mehregan","year":"1993","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0050","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1046\/j.1365-2133.1998.02183.x","article-title":"Localized mucosal involvement and severe pulmonary involvement in a young patient with paraneoplastic pemphigus associated with Castleman\u2019s tumour","volume":"138","author":"Kim","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0055","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00408-015-9732-8","article-title":"A systematic review of patients with Mucocutaneous and respiratory complications in paraneoplastic autoimmune multiorgan syndrome: Castleman\u2019s disease is the predominant malignancy","volume":"193","author":"Lee","year":"2015","journal-title":"Lung"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0060","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/ajcp\/aqaa053","article-title":"Predominant stroma-rich feature in hyaline vascular variant of Castleman disease is associated with paraneoplastic Pemphigus","volume":"154","author":"Wang","year":"2020","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0065","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-241374","article-title":"Paraneoplastic pemphigus caused by pre-existing stroma-rich variant of Castleman disease: from a pathologist\u2019s point of view","volume":"14","author":"Gwiti","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0070","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1001\/archdermatol.2012.1830","article-title":"Prognostic factors of paraneoplastic pemphigus","volume":"148","author":"Leger","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0075","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/bjd.14162","article-title":"Clinical and immunological findings in 104 cases of paraneoplastic pemphigus","volume":"173","author":"Ohzono","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0080","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.jaad.2018.03.043","article-title":"Risk factors for death and survival in paraneoplastic pemphigus associated with hematologic malignancies in adults","volume":"80","author":"Ouedraogo","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0085","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1440-0960.2012.00921.x","article-title":"Paraneoplastic pemphigus","volume":"54","author":"Yong","year":"2013","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0090","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1346-8138.2007.00322.x","article-title":"Paraneoplastic pemphigus","volume":"34","author":"Zhu","year":"2007","journal-title":"J Dermatol"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0095","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1046\/j.1365-2133.1999.03123.x","article-title":"Graft-versus-host disease-like immunophenotype and apoptotic keratinocyte death in paraneoplastic pemphigus","volume":"141","author":"Reich","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0100","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.ad.2017.04.024","article-title":"Paraneoplastic pemphigus. A life-threatening autoimmune blistering disease","volume":"108","author":"Tirado-S\u00e1nchez","year":"2017","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0105","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJM199905063401805","article-title":"The mechanism of respiratory failure in paraneoplastic pemphigus","volume":"340","author":"Nousari","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0110","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1440-1843.2008.01397.x","article-title":"Constrictive bronchiolitis associated with paraneoplastic autoimmune multi-organ syndrome","volume":"14","author":"Maldonado","year":"2009","journal-title":"Respirology"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0115","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00277-021-04499-8","article-title":"Fatal progression of bronchiolitis obliterans in spite of complete remission of follicular lymphoma and paraneoplastic pemphigus","volume":"101","author":"Kishi","year":"2022","journal-title":"Ann Hematol"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0120","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/crj.13465","article-title":"Clinical and pathological features of bronchiolitis obliterans requiring lung transplantation in paraneoplastic pemphigus associated with Castleman disease","volume":"16","author":"Chen","year":"2022","journal-title":"Clin Respir J"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2023.08.020","article-title":"Paraneoplastic pemphigus\/paraneoplastic autoimmune multiorgan syndrome: part I. Clinical overview and pathophysiology","volume":"91","author":"Anderson","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0130","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jaad.2024.10.013","article-title":"A systematic review of paraneoplastic pemphigus and paraneoplastic autoimmune multiorgan syndrome: clinical features and prognostic factors","volume":"92","author":"Zou","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0135","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1046\/j.1365-2133.2002.04992.x","article-title":"Paraneoplastic pemphigus in children and adolescents","volume":"147","author":"Mimouni","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0140","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/pde.15138","article-title":"Paraneoplastic pemphigus associated with Castleman disease: a multicenter case series","volume":"40","author":"Barry","year":"2023","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0145","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/JID.2015.408","article-title":"Epiplakin is a paraneoplastic Pemphigus autoantigen and related to bronchiolitis obliterans in Japanese patients","volume":"136","author":"Tsuchisaka","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0150","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/sj.jid.5700198","article-title":"Epitopes in the linker subdomain region of envoplakin recognized by autoantibodies in paraneoplastic pemphigus patients","volume":"126","author":"Zhang","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012250","article-title":"The protease inhibitor alpha-2-macroglobulin-like-1 is the p170 antigen recognized by paraneoplastic pemphigus autoantibodies in human","volume":"5","author":"Schepens","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0160","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/jid.2013.65","article-title":"Anti-\u03b1-2-macroglobulin-like-1 autoantibodies are detected frequently and may be pathogenic in paraneoplastic pemphigus","volume":"133","author":"Numata","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0165","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1001\/archderm.136.5.652","article-title":"Lichenoid dermatitis in paraneoplastic pemphigus: a pathogenic trigger of epitope spreading?","volume":"136","author":"Bowen","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0170","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/bjd.15389","article-title":"Paraneoplastic pemphigus associated with Castleman disease: progression from mucous to mucocutaneous lesions with epitope-spreading phenomena","volume":"176","author":"Okahashi","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0175","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/cup.14004","article-title":"Paraneoplastic pemphigus: revised diagnostic criteria based on literature analysis","volume":"48","author":"Svoboda","year":"2021","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0180","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.oraloncology.2003.09.020","article-title":"Neoplasms associated with paraneoplastic pemphigus: a review with emphasis on non-hematologic malignancy and oral mucosal manifestations","volume":"40","author":"Kaplan","year":"2004","journal-title":"Oral Oncol"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0185","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1368-8375(98)00059-1","article-title":"Paraneoplastic pemphigus: a review","volume":"34","author":"Sklavounou","year":"1998","journal-title":"Oral Oncol"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0190","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1365-2133.2003.05659.x","article-title":"Paraneoplastic pemphigus in association with Castleman\u2019s disease","volume":"149","author":"Nikolskaia","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0195","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJM200307243490421","article-title":"CD8+ T lymphocytes in bronchiolitis obliterans, paraneoplastic pemphigus, and solitary Castleman\u2019s disease","volume":"349","author":"Hoffman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0200","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/modpathol.2013.202","article-title":"Monoclonality and cytogenetic abnormalities in hyaline vascular Castleman disease","volume":"27","author":"Chang","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0205","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3673","article-title":"Features and risk factors for paraneoplastic autoimmune multiorgan syndrome in 145 Chinese patients","volume":"100","author":"Wang","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0210","doi-asserted-by":"crossref","first-page":"472","DOI":"10.2340\/00015555-1746","article-title":"First-line combination therapy with rituximab and corticosteroids is effective and safe for pemphigus","volume":"94","author":"Cho","year":"2014","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0215","doi-asserted-by":"crossref","first-page":"572","DOI":"10.4103\/idoj.IDOJ_640_20","article-title":"Paraneoplastic autoimmune multiorgan syndrome: a retrospective study from a tertiary care center in South India","volume":"12","author":"Sathishkumar","year":"2021","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0220","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/1097-0142(195607\/08)9:4<822::AID-CNCR2820090430>3.0.CO;2-4","article-title":"Localized mediastinal lymph node hyperplasia resembling thymoma","volume":"9","author":"Castleman","year":"1956","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0225","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/bjh.15019","article-title":"The full spectrum of Castleman disease: 273 patients studied over 20 years","volume":"180","author":"Oksenhendler","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0230","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00428-025-04171-w","article-title":"The morphological spectrum of Castleman disease and related disorders: a report from the lymphoma workshop of the 22nd meeting of the European Association of Hematopathology","volume":"487","author":"Gasljevic","year":"2025","journal-title":"Virchows Arch"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0235","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s12032-009-9304-y","article-title":"A critical role of surgery in the treatment for paraneoplastic pemphigus caused by localized Castleman\u2019s disease","volume":"27","author":"Fang","year":"2010","journal-title":"Med Oncol"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0240","doi-asserted-by":"crossref","DOI":"10.1186\/1477-7819-6-83","article-title":"Paraneoplastic pemphigus regression after thymoma resection","volume":"6","author":"Barbetakis","year":"2008","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0245","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1001\/archderm.1993.01680280071014","article-title":"Paraneoplastic pemphigus is a distinct neoplasia-induced autoimmune disease","volume":"129","author":"Camisa","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0250","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1365-4632.2009.03995.x","article-title":"Paraneoplastic pemphigus\/paraneoplastic autoimmune multiorgan syndrome","volume":"48","author":"Sehgal","year":"2009","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0255","doi-asserted-by":"crossref","DOI":"10.23937\/2469-5750\/1510046","article-title":"Paraneoplastic pemphigus","volume":"3","author":"Zhong-Shuai","year":"2017","journal-title":"J Dermatol Res Ther"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0260","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1586\/1744666X.4.3.351","article-title":"Rationale and efficacy for the use of rituximab in paraneoplastic pemphigus","volume":"4","author":"Vezzoli","year":"2008","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0265","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/archderm.134.6.706","article-title":"Immunoapheresis in paraneoplastic pemphigus","volume":"134","author":"Schoen","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.anndiagpath.2025.152602_bb0270","first-page":"492","article-title":"Clinical analysis of Unicentric Castleman\u2019s disease with paraneoplastic Pemphigus and bronchiolitis obliterans","volume":"39","author":"Zhen","year":"2017","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913425001674?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913425001674?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T12:53:38Z","timestamp":1769172818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913425001674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":54,"alternative-id":["S1092913425001674"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2025.152602","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From the archives of MD Anderson Cancer Center: Paraneoplastic autoimmune multiorgan syndrome (PAMS) associated with stroma-rich Castleman disease","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2025.152602","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152602"}}